Orrin Hatch: “The U.S. bio-pharmaceutical industry is the poster child for this 21st-century economy.”

Having a confirmed Commissioner, and sustained leadership, will benefit the Social Security Administration.

I urge Congress pass the OPEN ACT before the end of this year.

The Finance Committee has worked with the Treasury Department to ensure proper responsiveness to committee inquiries. We are continuing to review these matters to determine what further oversight is required.

Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.